Abstract:The breast cancer susceptibility gene BRCA1 is mutated in about one half of all hereditary breast cancer cases, and its expression is frequently decreased in sporadic cancers. Previously, we demonstrated a functional interaction between the BRCA1 and estrogen receptor-alpha (ER-alpha) proteins that causes inhibition of ER-alpha signaling. Here, we examined the role of growth factor signaling pathways in modulating this interaction. We found that underexpression of BRCA1 caused ligand-independent activation of ER-alpha that was mediated through phosphatidylinositol-3 kinase (PI3K)/c-Akt signaling. BRCA1 underexpression also enhanced estrogen-inducible ER-alpha activity in a PI3K/Akt-dependent manner. Exogenous c-Akt conferred estrogen-independent ER-alpha activation and rescued the BRCA1 repression of estrogen-stimulated ER-alpha activity. BRCA1 knockdown stimulated c-Akt activity, in part, by inhibiting the activity of protein phosphatase 2A, an enzyme that dephosphorylates Akt. ERs with point mutations of several growth factor-targeted serine residues (S167A, S118A, and S118/167A) were resistant to repression by BRCA1, although the single point mutant receptors still associated with the BRCA1 protein. The enhanced ER-alpha activity attributable to BRCA1 knockdown was dependent, in part, on serine residues 167 and 118 of ER-alpha. BRCA1 knockdown caused an increase in ER-alpha phosphorylation on serine-167 (but not serine-118 or serine-104/106) that was dependent on PI3K/Akt signaling and was mimicked by pharmacologic inhibition of protein phosphatase 2A. These findings suggest that BRCA1 regulates Akt signaling and the PI3K/Akt pathway modulates the ability of BRCA1 to repress ER-alpha, in part through serine phosphorylation events in the activation function-1 domain of ER-alpha.

Data from Absence of the Full-Length Breast Cancer–Associated Gene-1 Leads to Increased Expression of Insulin-Like Growth Factor Signaling Axis Members

Absence Of Full-Length Brca1 Sensitizes Mice To Oxidative Stress And Carcinogen-Induced Tumorigenesis In The Esophagus And Forestomach

Supplementary Figure 1 from Absence of the Full-Length Breast Cancer–Associated Gene-1 Leads to Increased Expression of Insulin-Like Growth Factor Signaling Axis Members

Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer

Data from Impaired Skin and Mammary Gland Development and Increased γ-Irradiation–Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1

Abstract #4440: BRCA1 Modulates Malignant Cell Behavior, the Expression of Survivin and Chemosensitivity in Human Breast Cancer Cells

Loss of Function of BRCA1 Promotes EMT in Mammary Tumors Through Activation of TGFβR2 Signaling Pathway

Abstract P4-05-01: Genetic Analysis of the Role of Brca1 in Suppression of Basal-Like Breast Cancer

BRCA1 Regulates Human Mammary Stem/progenitor Cell Fate

Impaired Skin And Mammary Gland Development And Increased Gamma-Irradiation-Induced Tumorigenesis In Mice Carrying A Mutation Of S1152-Atm Phosphorylation Site In Brca1

Mouse Models for BRCA1-associated Breast Cancer

BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway

Growth Factor Signaling Pathways Modulate Brca1 Repression of Estrogen Receptor-Alpha Activity

Hyperplasia and Spontaneous Tumor Development in the Gynecologic System in Mice Lacking the BRCA1-Δ11 Isoform

Atm-Chk2-P53 Activation Prevents Tumorigenesis At An Expense Of Organ Homeostasis Upon Brca1 Deficiency

Brca1 Suppresses Epithelial-To-Mesenchymal Transition And Stem Cell Dedifferentiation During Mammary And Tumor Development

Data from BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress

A Targeted Disruption of the Murine Brca1 Gene Causes Γ-Irradiation Hypersensitivity and Genetic Instability

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

Negative Regulation Of Akt Activation By Brca1

A Selective Requirement for 53BP1 in the Biological Response to Genomic Instability Induced by Brca1 Deficiency.